— Know what they know.
Not Investment Advice

VNDA NASDAQ

Vanda Pharmaceuticals Inc.
1W: -3.0% 1M: -9.2% 3M: +7.6% YTD: -24.9% 1Y: +39.6% 3Y: +0.8% 5Y: -66.8%
$6.19
-0.02 (-0.32%)
After Hours: $6.32 (+0.13, +2.10%)
Weekly Expected Move ±9.2%
$5 $6 $6 $7 $7
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 30 · $372.2M mcap · 54M float · 4.51% daily turnover · Short 59% of daily vol

📊 Key Metrics

TTM
$218M
Revenue
+8.2% YoY
$-240M
Net Income
-441.4% YoY
$-127M
Free Cash Flow
-121.8% YoY
90.0%
Gross Margin
-97.1%
Op. Margin
-93.9%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-55.3%
ROA-41.8%
ROIC-166.8%

Valuation

P/E-1.5
P/B1.3
EV/EBITDA-1.1

Leverage

Debt/Equity0.04
Current Ratio2.39
Interest Cov.0.0x

Quality Scores

Piotroski F2/9
Altman Z0.28
Beneish M-3.63

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms